Provided are a 4-[5-(pyridine-4-yl)-1H-1,2,4-triazole-3-yl]pyridine-2-carbonitrile crystalline polymorph, which is useful as a pharmaceutical product, and a production method therefor. The present invention relates to a 4-[5-(pyridine-4-yl)-1H-1,2,4-triazole-3-yl]pyridine-2-carbonitrile crystalline polymorph, and three different crystalline forms are obtained by purification via a salt, storage under humidified conditions or recrystallization.Buluş, 4-[5-(piridin-4-il)-1H-1,2,4-triazol-3-il]piridin-2-karbonitril?in kristalli bir polimorfu ve bunun için bir üretim yöntemi ile ilgilidir.